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Chapter 24 
Avian Chlamydiosis  
Daisy Vanrompay1 
$a$ Introduction 
$b$ Definition and Synonyms 
Avian chlamydiosis is caused by the bacterium Chlamydia 
psittaci. Avian chlamydiosis is a respiratory disease, usually 
systemic and occasionally fatal. Today, C. psittaci has been 
demonstrated in about 465 bird species spanning 30 bird orders 
(61). This chapter primarily covers avian chlamydiosis as it 
occurs in birds raised commercially for meat and egg production. 
It should be noted that the disease in pet birds is quite 
similar, and the disease characteristics, transmission, and 
diagnosis are essentially the same. An update of the disease and 
control procedures for chlamydiosis in companion birds was 
published (104) and is on the American Veterinary Medical 
Association (AVMA) and Centers for Disease Control and 
Prevention (CDC) Web sites. 
Chlamydia psittaci can be transmitted to humans. The disease 
in birds and humans originally was called psittacosis or parrot 
fever (80) as it was first recognized in psittacine birds and in 
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Table 2. Chlamydiaceae taxonomy (adapted from Schautteet and Vanrompay, 2011) 
	  
 
 
	   Chlamydial taxonomy in the late 
1990s 
Chlamydial taxonomy used in the twenty-first century 
 
(Everett et al., 1999) 
Chlamydial taxonomy used on the twenty-first 
century (Stephens et al., 2009) 
Order Chlamydiales Chlamydiales Chlamydiales	  
Family	   Chlamydiaceae	   Chlamydiaceae,	  Simkaniaceae,	  Parachlamydiaceae,	  
	  Waddliaceae	  
Chlamydiaceae,	  Simkaniaceae,	  
Parachlamydiaceae,	  Waddliaceae	  
Genus	   Chlamydia	   	   Chlamydia	   	   Chlamydophila 	   Chlamydia	   	  
Species	   C.	  trachomatis	   Trachoma	  biovar	   C.	  trachomatis	   Trachoma	  biovar	   	   	   C.	  trachomatis	   Trachoma	  biovar	  	   	   LGV	  biovar	   	   LGV	  biovar	   	   	   	   LGV	  biovar	  	   	   Murine	  biovar	   C.	  muridarum	   	   	   	   C.	  muridarum	   	  	   	   Porcine	  biovar	   C.	  suis	   	   	   	   C.	  suis	   	  	   C.	  pneumoniae	   Human	  biovar	   	   	   C.	  pneumoniae	   TWAR	  biovar	   C.	  pneumoniae	   TWAR	  biovar	  
	   	   Koala	  biovar	   	   	   	   Koala	  biovar	   	   Koala	  biovar	  	   	   Equine	  biovar	   	   	   	   Equine	  biovar	   	   Equine	  biovar	  	   C.	  psittaci	   Avian	  subtype	   	   	   C.	  psittaci	   	   C.	  psittaci	   	  	   	   Abortion	  subtype	   	   	   C.	  abortus	   	   C.	  abortus	   	  	   	   Feline	  subtype	   	   	   C.	  felis	   	   C.	  felis	   	  	   	   Guinea-­‐pig	  subtype	   	   	   C.	  caviae	   	   C.	  caviae	   	  	   C.	  pecorum	   	   	   	   C.	  pecorum	   	   C.	  pecorum	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humans associated with psittacine birds. Ornithosis was a term 
introduced in 1941 by Meyer (76, 77) to differentiate the 
disease in or contracted from domestic and wild fowl from the 
disease in or contracted from psittacine birds. However, the two 
syndromes are actually the same (84). Nowadays, we speak of 
chlamydiosis in birds and psittacosis in humans. 
$b$ Public Health Significance 
Chlamydia psittaci can infect humans and precautions should 
be taken when handling infected birds or contaminated materials. 
Most infections are through inhalation of infectious aerosols; 
thus, poultry processing plant employees are especially at risk, 
as are farm workers, veterinarians, poultry inspectors and 
taxidermists (26-28, 35, 42, 64, 120, 138).  
In humans, the incubation period is  usually 5–14 days; 
however, longer periods are known (104). Infections vary from 
inapparent to severe systemic disease with pneumonia (14). 
Secondary spread among humans rarely occurs. Because the disease 
is rarely fatal in properly treated patients, awareness of the 
danger and early diagnosis are important.  
 
$a$ History 
 The first description of a psittacosis outbreak dates from 
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1879 and was described by Jacob Ritter, linking the disease to 
pet parrots and finches (94). Historical aspects of chlamydia-
related diseases in animals and humans are reviewed by Andersen 
and Vanrompay (1) and more recently by Pospischil (92).  
$a$ Etiology 
$b$ Classification 
The members of the family Chlamydiaceae, order Chlamydiales 
are obligate, intracellular gram-negative bacteria. In 1999, 
Everett et al., (33) proposed a reassignment from the single 
genus Chlamydia into two genera, Chlamydia and Chlamydophila, 
based on clustering analyses of the 16S rRNA and 23S rRNA genes 
(Table 24.1). However, recent comparative genome analyses are 
consistent with the conclusion that host-divergent strains of 
chlamydia are biologically and ecologically closely related. The 
previous taxonomic separation of the genus based on ribosomal 
sequences is neither consistent with the natural history of the 
organism revealed by genome comparisons, nor widely used by the 
chlamydia research community eleven years after its 
introduction. Consequently, it was proposed to reunite the 
Chlamydiaceae into a single genus, Chlamydia (63) (Table 24.1). 
Accordingly, the chlamydia nomenclature is used in this chapter. 
$b$ Morphology and Staining 
The three morphologically distinct forms of Chlamydia are 
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termed elementary body (EB), reticulate body (RB), and 
intermediate body (IB). The EB (Fig. 24.1) is a small, electron-
dense, spherical body, about 0.2–0.3 mm in diameter. The EB is 
the infectious form of the organism, which attaches to the 
target epithelial cell and gains entry. The EBs have a highly 
electron-dense nucleoid, located at the periphery of the EB and 
clearly separated from an electron-dense cytoplasm. Following 
entry into the host cell, the EB expands in size to form the RB, 
which is the intracellular metabolically active form. The RB 
measures approximately 0.5–2.0 mm in diameter (Fig. 24.2). The 
RB divides by binary fission and thereafter matures into new 
EBs. During this maturation, morphologically intermediate forms 
(IB), measuring about 0.3–1.0 mm in diameter, can be observed. 
The IB has a central electron-dense core with radially arranged 
individual nucleoid fibers surrounding the core. Cytoplasmic 
granules are tightly packed at the periphery of the IB and are 
separated from the core by a translucent zone. 
The Gram stain is of no practical value in identifying 
chlamydiae as the presence of peptidoglycan in the chlamydial 
cell envelope has yet to be established although the genes 
encoding the enzymes for peptidoglycan biosynthesis are present 
(108).  Chlamydiae are large enough to be seen with a light 
microscope using special optics or selective stains. Chlamydiae 
can be observed in swab smears or touch impressions of infected 
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tissues by staining them with Castaneda, Giemsa, Giménez (40), 
modified Giménez, Machiavello, or Stamp methods (2). Chlamydiae 
appear dark purple with Giemsa; blue with Castaneda; and red 
with Machiavello, Giménez, modified Giménez and Stamp stains 
against contrasting backgrounds. The modified Giménez method 
(136) is most often used.  
$b$ Biochemical Properties 
The RB is the intracellular, metabolically active form. 
Although DNA and RNA are both found in the EB and the RB, the 
ratio of RNA to DNA is greater in the RB. The RBs synthesize 
their own DNA, RNA, and protein, but some of their metabolic 
capabilities are limited when compared with free-living, 
colonizing bacteria. For example, they cannot complete the 
pentose cycle and do not use pyruvate by way of the 
tricarboxylic acid cycle. They can, however, catabolize pyruvic, 
aspartic, and glutamic acids, generating CO2 and 2- and 4-carbon 
residues. 
$b$ Susceptibility to Chemical and Physical Agents 
The survival of microorganisms in aerosols depends on five 
different factors: relative humidity (RH), temperature, level of 
oxygen, presence of UV radiation, and constituents of the 
aerosol and of air (116). The degree to which these factors 
influence the survival of microorganisms in aerosols depends 
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strongly on the type of microorganism and the time it has to 
spend in the aerosol. In general, the following rule applies. 
Gram-negative bacteria survive the best at low temperatures and 
RH. Thus, C. psittaci remains viable at low temperatures and is 
resistant to desiccation. The bacterium is highly susceptible to 
repeated freeze-thawing cycles and is destroyed within 3 minutes 
when exposed to UV-light. 
Chlamydiae are highly susceptible to chemicals that affect 
their lipid content or the integrity of their cell walls. Even 
in a milieu of tissue debris they are inactivated rapidly by 
surface-active compounds, such as quaternary ammonium compounds 
and lipid solvents (104). Infectivity is destroyed within 
minutes, by exposure to common disinfectants such as 
benzalkonium chloride, alcoholic iodine solution, 70% ethanol, 
3% hydrogen peroxide, and silver nitrate; but they are resistant 
to cresol compounds and lime. Dilute suspensions (20%) of 
infectious tissue homogenates are inactivated by incubation for 
5 minutes at 56°C, 48 hours at 37°C, 12 days at 22°C, and 50 
days at 4°C (88).  
$b$ Antigenic Structure and Toxins 
The cysteine-rich major outer membrane protein (MOMP) is well 
studied. It has a molecular weight of 40 kDa and represents 
approximately 60% of the weight of the outer membrane. The MOMP 
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of C. psittaci is an immunodominant protein, and there is 
considerable evidence that antibodies to surface-accessible 
epitopes of MOMP have a protective role in immunity to 
chlamydial infection (23). The outer membrane protein A (ompA) 
gene (formerly referred to as omp1 gene) encodes the MOMP. The 
ompA gene contains 5 conserved- and four variable-sequence 
regions, VS1 to VS4, which encode for the variable-protein 
domains VDI to VDIV. VDI, VDII, and VDIV especially protrude 
from the C. psittaci membrane. Epitope mapping has shown the 
presence of genus- and species-specific antigenic determinants 
within the conserved regions. However, species-specific 
antigenic determinants have also been found in the most 
conserved parts of VDIV. Serovar-specific antigenic determinants 
are located within VDI and VDII. Monoclonal antibodies to the 
highly immunoaccessible serovar-specific epitopes on the MOMP 
can passively neutralize chlamydial pathogenicity and 
infectivity. Monoclonal antibodies to genus-, species-, or 
serovar-specific epitopes on the MOMP are excellent tools for 
specific chlamydial diagnosis. 
A chlamydial cysteine-rich heat shock protein 60 (hsp60 or 
GroEL) has been described that is cross-reactive with other 
gram-negative bacteria such as Escherichia coli, Neisseria 
gonorrhoeae, and Coxiella burnetii (144). Thus, the presence of 
cross-reactive epitopes on the chlamydial outer membrane should 
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be kept in mind when choosing or interpreting a specific 
diagnostic test.  
Other chlamydia proteins under study are OmcA (EnvA or Omp3), 
OmcB (EnvB or Omp2), Hc1, RpoB’, RpoB, polymorphic outer 
membrane proteins (pmps), PorB (OmpB), Omp85, elongation factor 
Tu (EF-Tu/TufA), DnaK (hsp70), and OprB (19, 62, 79, 81, 107, 
114).  
The chlamydial lipopolysaccharide (LPS) is also an essential 
constituent of the outer membrane and, like the MOMP, represents 
one of the major surface-exposed antigens of chlamydiae in both 
the EB and the RB. It has a molecular weight of 10 kDa and is 
chemically and serologically related to the LPS of gram- 
negative Enterobacteriaceae. In fact, the chlamydial LPS 
contains several antigenic determinants cross-reacting with the 
LPS of enterobacterial Re mutants of Salmonella species and 
Acinetobacter calcoaceticus (20, 83). However, the chlamydial 
LPS contains in its saccharide moiety, a trisaccharide of 3-
deoxy-D-manno-2-octulosonic acid (Kdo) of the sequence 
αKdo(2→8)-αKdo-(2→4)-αKdo. This antigenic epitope is shared 
only by all members of the genus Chlamydia and, thus, represents 
a Chlamydiaceae-specific antigen useful for specific diagnosis 
(21). 
 A putative chlamydial cytotoxin has been described (16, 22) 
in all chlamydia genomes studied so far (103, 106), including 
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the C. psittaci 6BC and Cal10 strains (48). So far, extensive 
comparisons among C. psittaci clinical isolates have not been 
made, nor has the actual function of the C. psittaci putative 
cytotoxin or its cellular localization been established with 
certainty.  
$b$ Strain Classification 
$c$ Antigenicity 
All Chlamydiaceae are recognized by monoclonal antibodies 
(MAbs) that detect the LPS αKdo(2→8)-αKdo-(2→4)-αKdo. Chlamydia 
species have a common antigenic epitope in variable segment 4 of 
the MOMP: NPTI, TLNPTI, LNPTIA, or LNPTI. C. psittaci strains 
are recognized by serovar-specific monoclonal antibodies. The 8 
known C. psittaci serovars (A to F, M56, and WC) can be 
distinguished by use of a panel of serovar-specific monoclonal 
antibodies in a micro-immunofluorescence test (3, 6, 134). 
However, serotyping is currently rarely performed as the 
serovar-specific MAbs are not provided by a commercial supplier, 
and as serotyping appears less discriminatory compared to the 
newly developed molecular characterization methods (66, 89, 
125).  
$c$ Genetic, molecular  
Chlamydia species are mostly distinguished by analysis of: 
i) full-length 16S and 23S rDNAs, ii) the 16S-23S intergenic 
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spacer (rrn spacer), iii) signature sequences in the 16S and 23S 
ribosomal genes (33, 34), iv) the Chlamydiaceae RNase P RNA gene 
(rnpB) encoding a ribonucleoprotein complex that removes 5’ 
leader sequences from tRNA precursors during tRNA biosynthesis 
(54), or of v) the outer membrane protein A (ompA) gene encoding 
the Chlamydia major outer membrane protein (MOMP). PCR-RFLP, 
nested (multiplex) PCR, TaqMan-based real-time PCR, micro 
arrays, PCR followed by high resolution melt (HRM) curve 
analysis of the amplified 16S rRNA gene, as well as gene 
sequencing has been described for identifying Chlamydia species 
in livestock (34, 36, 74, 96, 99).  
Genotyping of C. psittaci by AluI restriction fragment 
length polymorphism (RFLP) analysis of the ompA gene was 
introduced in 1995, as a more sensitive, more reliable sub-
typing method compared to C. psittaci serotyping (102). RFLP 
analysis of the ompA gene of all known C. psittaci serovars 
revealed corresponding restriction patterns or genotypes (5, 
127). More recently, ompA genotyping by real-time PCR using 
genotype-specific probes has been described, allowing the 
detection of an additional variant described as the avian C. 
psittaci genotype E/B (36, 37). A few years ago, a genotyping 
micro array was introduced allowing the identification of all 
currently known avian and mammalian C. psittaci genotypes (98).  
Genotyping is very convenient, as it is a rapid, powerful 
	   11	  
technique that can be used directly on clinical samples in any 
veterinary clinical laboratory.  
Some avian ompA genotypes appear to occur more often in a 
specific order of birds. Genotype A for instance, is endemic 
among psittacine birds (Psittacidae) but is has also been found 
in turkeys, ducks, pigeons and Passeriformes. Genotype B is 
endemic in pigeons (Columbiformes) but can also infect chickens, 
turkeys, ducks, Psittacidae and Passeriformes (6). Waterfowl 
(Anseriformes), like ducks and geese most frequently seem to be 
infected with genotype C. Genotype C has also been detected in 
chickens and pigeons (29, 145). Genotype D strains are most 
often associated with turkeys, but genotype D strains can also 
infect pigeons. More recently, genotype D has also been detected 
in chickens (28). Genotype E, also known as Cal-10, MP, or MN 
was first isolated during an outbreak of pneumonia in humans 
during the early 1930s. Later on, genotype E isolates were 
obtained from a variety of bird species including, turkeys, 
pigeons, ducks, ostriches, and rheas. Genotype F is represented 
by the psittacine isolates VS225, Prk Daruma, 84/2334 (125) and 
10433-MA, but has also been isolated on a Belgian turkey farm 
(123). Genotype E/B is often found in ducks, but it has also 
been detected in parrots (52), in turkeys (118) and in pigeons 
(38). The mammalian M56 and WC genotypes were isolated during an 
outbreak in muskrats and hares and during an outbreak of 
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enteritis in cattle, respectively. All genotypes should be 
considered to be readily transmissible to humans. 
Occasional detections of C. abortus (68, 109) and so far 
non-classified chlamydial agents (65), as well as genetic 
evidence on intermediate strains between C. psittaci and C. 
abortus (125) suggest that the spectrum of Chlamydiaceae spp. 
encountered in birds is not confined to a single species. 
Recently, Pannekoek et al., (98), used multi-locus sequence 
typing (MLST) for studying the population structure of C. 
psittaci and C. abortus, as Van Loock et al., (125) showed that 
ompA sequencing and even sequencing of the rrn spacer (33, 34) 
can not always distinguish C. psittaci from C. abortus. The 
obtained MLST scheme was based on the partial sequences of seven 
housekeeping genes enoA, fumC, gatA, gidA, hemN, hflX and oppA, 
representative for the whole genome sequence. MLST of C. 
psittaci strains resulted in 11 unique sequence types (STs). 
MLST was extremely useful for distinguishing the phylogenetic 
highly related species C. psittaci and C. abortus. 
Interestingly, according to MLST, the ompA genotype F strain 
84/2334 appears to be a C. abortus strain instead of a C. 
psittaci strain (89).  
According to Wang et al., (140), high-resolution genotyping 
within one chlamydia species can be achieved by multilocus 
variable-number tandem-repeat (VNTR) analysis (MLVA) in 
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combination with ompA sequencing (MLVA-ompA). This method is 
highly accurate for distinguishing closely related strains 
within one Chlamydia species. VNTR analysis was used for 
exploring the diversity of C. psittaci. For C. psittaci, 20 
selected genetic loci were initially tested on 9 avian reference 
strains including representatives of all major ompA genotypes (A 
to F and E/B). Thereafter, 8 loci were retained for a more 
complete study performed on over 150 C. psittaci isolates from 
different bird species and geographical origins. The MLVA system 
provides an additional level of discrimination within the C. 
psittaci species, with 20 distinct patterns identified to date 
(66). MLVA could provide the high-resolution needed for local 
epidemiology and accurate contact tracing in case zoonosis 
contracted from poultry. However, current MLVA (and MLST) 
methods are still easier to perform on culturable samples or 
clinical samples of C. psittaci infected poultry with a high 
bacterial DNA load.  
$c$ Pathogenicity 
Chlamydia psittaci strains isolated from birds fall into 
two general categories: 1) Highly virulent strains that cause 
acute epidemics in which 5–30% of affected birds die and 2) less 
virulent strains that cause slowly progressive epidemics. 
Strains of both high and low virulence appear to have equal 
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ability to spread rapidly through a flock, as evidenced by 
serologic test results. Highly virulent strains are isolated 
most often from turkeys and occasionally from ducks, chickens, 
pigeons and clinically normal wild birds.  
The isolates serotyped from some of the earlier outbreaks 
with high mortality have been of serotype D (Andersen, 1991b; 
Vanrompay et al., 1993b). More recently, highly virulent strains 
have been characterized in European turkeys, ducks and chickens. 
A highly virulent Genotype D strain was isolated on a French 
chicken farm (Vanrompay et al., 2012, unpublished results) as 
well as a highly virulent not yet characterized strain on 
another French chicken farm (65). Highly virulent strains cause 
rapidly fatal disease in natural and experimental hosts with 
lesions characterized by extensive vascular congestion and 
inflammation of vital organs. Highly virulent strains have a 
broad spectrum of pathogenicity for laboratory animals and can 
cause serious human infections (some fatal) in poultry handlers 
and laboratory research workers. Strains of low virulence cause 
slowly progressive epidemics with a mortality rate of less than 
5% when uncomplicated by secondary bacterial or parasitic 
infection. Strains of this category are routinely isolated from 
pigeons and ducks and occasionally from turkeys, sparrows, and 
other wild birds. The turkey isolates from outbreaks with low 
mortality have been of genotype B or E. Birds infected with 
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these strains usually do not develop the severe vascular damage 
typical in birds infected with the virulent strains, nor do they 
have the severe clinical signs (115). 
$c$ Virulence factors  
The initial event in the infectious process begins with 
attachment of C. psittaci EBs to microvilli at the apical 
surface of a susceptible columnar epithelial cell (58) (Fig. 
24.1). The EB travels down the microvillus and locates in 
indentions of the eukaryotic plasma membrane, some of which 
resemble coated pits. The bases of micropilli represent areas of 
active transport of extracellular materials into the cells and, 
therefore, might assist rapid and efficient entry of EBs. After 
1–3 hours, the EBs are internalized in invaginations of the 
plasma membrane. Uptake of C. psittaci is an endocytic 
mechanism, involving microfilament-dependent and/or independent 
processes. The C. psittaci containing endocytic vesicles or 
vacuoles escape interaction with lysosomes and proceed in about 
8–12 hours to the nuclear area, where EBs are converted to RBs. 
Conversion to RBs primarily involves reduction of disulfide bond 
cross-linking among the outer membrane proteins altering the EB 
cell wall. Synthesis of DNA, RNA, and proteins is initiated, 
permitting growth and binary fission of the RBs. Binary fission 
is characterized by the appearance of typical “hour-glass” 
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profiles inside the vacuole (Fig. 24.2). The enlarging vacuole 
is also termed an “inclusion.” C. psittaci microorganisms do not 
always remain within the inclusion throughout their 
intracellular development. In some cases and in apparent 
correlation with high virulence of strains, the inclusion 
membrane seems to degrade during the active multiplication, 
liberating the bacteria into the cytoplasm of the host cell 
(128). About 30 hours after internalization of the EB, the first 
RBs are reorganized into newly formed EBs. At about 48–50 hours, 
the developing chlamydial inclusion may contain anywhere from 
100–500 progeny, depending on the characteristics of the C. 
psittaci strain (Fig. 24.3). With most C. psittaci strains, the 
host cell has undergone severe degenerative changes, and 
microorganisms are released by lysis (Fig. 24.4). Exocytosis of 
the inclusion, followed by a “healing” or closing of the open-
cavern structures where the inclusion had existed, has been 
reported (128). Persistent infections may occur with aberrant 
non-replicating RBs remaining inside the host cell cytoplasm. 
Since long, unique rosette-like structures and projections 
have been observed on the surface of both EBs and RBs of 
C. psittaci strain Mn (73). Shortly after the first description 
of a Type III secretion system (T3SS) in C. caviae (GPIC 
strain)(59), Bavoil and Hsia speculated that Matsumoto’s 
projections are in fact functional T3SSs, injecting chlamydial 
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virulence proteins into the host cell cytoplasm (10). A detailed 
description of the C. psittaci T3SS and the role of the 
chlamydial T3SS in virulence can be found in recent papers (13, 
15, 18, 91).  
Outer virulence factors under study are the polymorphic 
membrane proteins (pmps) (114). The pmps belong to the family of 
autotransporters. Although specific roles in pathogenesis have 
been described for some pmps, including adhesion their role in 
the growth and development of Chlamydiaceae is still unclear 
(78, 113).  
Chlamydiaceae can also engage in a long-term relationship 
with the host cell, a phenomenon known as persistence, in which 
no visible growth of the chlamydial organisms can be observed. 
The normal developmental cycle can be interrupted by a number of 
conditions and agents, such as antibiotics, nutrient 
deprivation, or immune factors, interferon-gamma (IFN-γ) in 
particular (41). This is generally accompanied by the 
development of relatively small inclusions, enlarged 
pleiotrophic aberrant RBs and inhomogeneity of the inclusions. 
Aberrant RBs accumulate chromosomes, but genes for cell division 
are no longer expressed. Once the stress-inducing factor is 
removed, aberrant RBs revert to normal RBs, complete the 
developmental cycle and generate infectious EBs. 
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$a$ Pathobiology and Epidemiology 
$b$ Incidence and Distribution  
Avian chlamydiosis occurs worldwide, with the incidence and 
distribution varying greatly with the species of bird and the 
genotype of the chlamydial organism. The economic losses in 
poultry and the human infections usually follow a sporadic 
pattern. Antibiotics are been used extensively to control the 
spread of the disease in birds and to reduce the risk to humans.  
The disease pattern in turkeys has changed. Historically, 
most outbreaks were explosive and occurred in free-ranging birds 
(45, 51). These severe respiratory disease outbreaks were 
attributed to genotype D. Chlamydia was thought introduced from 
the outside. Nowadays, genotype D and sometimes genotype A is 
found in confinement turkeys when death losses are high, whereas 
genotype B is less virulent (6, 97). Introduction through 
vertical transmission (70, 141), or through infected hatchlings 
(27) might occur. Recent studies on turkeys in Belgium and 
France showed that highly and low virulent strains (genotypes A, 
B, D, E, E/B and F) are widely distributed in commercial turkeys 
and may be endemic. Chlamydia is part of the turkey respiratory 
disease complex (123). Infection of turkeys with C. psittaci 
also seems to predispose the animals to amore severe clinical 
outcome of a simultaneous or subsequent infection with E. coli, 
APV and/or ORT (121-123) 
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Information on the incidence and epidemiology of chlamydia in 
domestic ducks is more limited. In the United States, it has not 
been a significant problem although infections occur. Chlamydia 
psittaci infections in ducks seem to occur more often in 
Australia, China and Europe (9, 24, 49, 57, 69, 143). In Europe, 
the number of outbreaks, in ducks seems to be increasing (64). 
Former European isolates have been characterized as genotype C 
(134). More recently, outbreaks in French ducks were associated 
with human disease. Human samples and duck isolates exhibited 
the same PCR-RFLP restriction pattern, which appeared to be an 
intermediate between genotypes A and B. Analysis of ompA gene 
sequences and comparison to those of the type strains showed 
that the isolates could not be strictly assigned to any of the 
generally accepted C. psittaci genotypes. Further analysis by 
MLVA of the PCR-positive human samples revealed two distinct 
patterns, which were related to previously isolated C. psittaci 
duck strains (64). 
Reports on C. psittaci outbreaks on chicken farms or reports 
on zoonotic transmissions linked to contact with C. psittaci-
infected chickens are extremely rare. It could be the case that 
chickens rarely become infected and/or that the strains 
infecting chickens are less virulent, presenting a minor risk 
for humans. Recently, we investigated the occurrence of C. 
psittaci by performing a retrospective study with 300 serum 
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samples collected in 2005 from 10 randomly selected chicken 
breeder, broiler, and layer farms in Belgium. Sera were examined 
by a recombinant MOMP-based enzyme-linked immunosorbent assay 
(ELISA)(139). We obtained 98, 95, and 95% seropositive results 
for layers, broilers, and breeders, respectively (28). 
Seropositive birds were found on all farms. Therefore, the 
statement that C. psittaci infections occur less frequently in 
chickens is not true. Recently, highly virulent genotype D 
strains (Vanrompay et al., 2012, unpublished results) as well as 
less virulent genotypes B, C and E/B strain have been found in 
chickens in Belgium, China, France and Germany (35, 65, 146; 
Vanrompay et al., 2012, unpublished results).  
In 2008, three cases of atypical pneumonia in individuals 
working at a French poultry slaughterhouse processing guinea 
fowl, ducks and especially chickens prompted an epidemiological 
survey in 10 poultry farms that had supplied birds. Using a 
Chlamydiaceae-specific real-time PCR assay, chlamydial agents 
were detected in 14 of 25 investigated flocks. The one duck 
flock being investigated was positive (20% of the tested animals 
positive). Additionally, 12 of 18 (67%) and 1 of 6 (17%) of the 
examined chicken and guinea fowl flocks were PCR positive, 
respectively. Positivity for the chicken flocks ranged from 10 
to 100%. For the positive guinea flow flock, 12.5% of the tested 
animals were positive. Rather unexpectedly, Chlamydia psittaci 
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was identified only in the positive duck flock, whereas 
ArrayTube DNA microarray testing indicated the presence of a new 
chlamydia agent in all other examined French poultry flocks. 
Further examination is needed to define the exact taxonomic 
status of this agent found in chickens and guinea fowl (65). 
Strains occurring naturally in birds are distinct from 
those in mammals (5, 6, 86). Attempts to infect birds with 
mammalian strains usually resulted in aborted or asymptomatic 
infections (60, 115).  
$b$ Natural and Experimental Hosts 
Chlamydiae or chlamydial antibodies have been found in at 
least 465 bird species (61). Common reservoirs of chlamydiae 
include wild and feral birds such as sea gulls, ducks, Canada 
geese, herons, egrets, pigeons, blackbirds, grackles, house 
sparrows, and killdeer, all of which freely intermingle with 
domestic birds. Highly virulent strains of C. psittaci can be 
carried by and excreted in large numbers without any apparent 
effect on these hosts.  
Experimental hosts of avian chlamydiae can include virtually 
any species of bird. Mammalian laboratory hosts used for avian 
chlamydiae are principally mice and occasionally guinea pigs. 
Mice and guinea pigs are the naturally hosts for C. muridarum 
and C. caviae, respectively. Investigators using these animals 
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should determine the chlamydial status of the breeding stock. 
Rabbits are refractory to clinical disease caused by avian 
chlamydiae, but they may be used to produce polyclonal 
antibodies. 
Younger domestic birds generally are more susceptible than 
older birds to infection, clinical disease, and mortality. 
However, maternal antibodies might protect against respiratory 
disease outbreaks on the farm. Infection in old turkeys, such as 
spent breeder hens, can go unnoticed unless birds are subjected 
to stressful conditions such as shipment to market on crowded 
trucks. Turkey toms may have a higher mortality rate than turkey 
hens (117). 
$b$ Transmission, Carriers, and Vectors  
Transmission of C. psittaci primarily occurs from one 
infected bird to another susceptible bird in close proximity. 
The agent is excreted in faeces and nasal discharges. Faecal 
shedding occurs intermittently and can be activated through 
stress caused by nutritional deficiencies, prolonged transport, 
overcrowding, chilling, breeding, egg laying, treatment or 
handling. Bacterial excretion periods during natural infection 
can vary depending on virulence of the strain, infection dose 
and host immune status. However, shedding may occur for several 
months. Transmission of chlamydiae occurs mainly through 
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inhalation of contaminated material and, sometimes, ingestion. 
Large numbers of C. psittaci cells can be found in respiratory 
tract exudate and faecal material of infected birds. The 
importance of the respiratory exudate has become more apparent. 
In turkeys, the lateral nasal glands become infected early and 
remain infected for more than 60 days. Choanal/oropharyngeal 
swabs are more consistent for isolation of the agent than faecal 
swabs, especially during early stages of infection. Direct 
aerosol transmission through aerosolization of respiratory 
exudate must be considered as the primary method of transmission  
Avian species, including domestic poultry sharing aquatic or 
moist soil habitats with wild infected aquatic birds may become 
infected via contaminated water. Granivorous birds like pigeons, 
doves, pheasants and house sparrows may become infected by dust 
inhalation in faeces contaminated barnyards and grain storage 
sites. The consumption of infected carcasses may transmit C. 
psittaci to host species that are predators or scavengers of 
other birds.  
Transmission of C. psittaci in the nest is possible. In many 
species, such as Columbiformes, cormorants, egrets, and herons, 
transmission from parent to young may occur through feeding, by 
regurgitation, while contamination of the nesting site with 
infective exudates or faeces may be important in other species, 
such as snow geese, gulls and shorebirds. Furthermore, C. 
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psittaci can be transmitted from bird to bird by blood-sucking 
ectoparasites such as lice, mites and flies or, less commonly, 
through bites or wounds. Transmission of C. psittaci by 
arthropod vectors would be facilitated in the nest environment. 
Mites from turkey nests can contain chlamydiae (30), and during 
an epidemic in turkeys in South Carolina, simulid flies were 
suspected as a possible method of transfer (85).  
Vertical transmission has been demonstrated in turkeys, 
chickens, ducks, parakeets, seagulls and snow geese, although 
the frequency appears to be fairly low (70, 141). However, it 
could serve as a route to introduce chlamydiae into a poultry 
flock. 
Chlamydia psittaci can be introduced into poultry through the 
wild bird population. Contaminated feed or equipment can also be 
a source of infection, and feed should therefore be protected 
from wild birds. Careful cleaning of equipment being used in 
several barns during one and the same production round is 
extremely important as C. psittaci can survive in faeces and 
bedding for up to thirty days (52). 
$b$ Incubation Period, Clinical Signs, Morbidity and 
Mortality, Pathology and Pathogenesis 
Turkeys 
In 1959, Page, (87) was the first to examine the pathogenesis 
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of a C. psittaci infection in commercial turkeys after 
inoculation by aerosol or by the oral route with a genotype D 
strain. In 1995, Vanrompay et al., (129) studied the 
pathogenesis of C. psittaci genotype A, B, and D strains in 
specific-pathogen-free turkeys kept in negative pressure 
isolation units by immunodetection, which allowed the precise 
determination of the tissue and cell tropism. In this study, 
turkeys were aerosol infected as this most likely represents the 
natural route of infection as demonstrated by Page (87). From 
these studies, the following pathogenic sequence of events can 
be deduced for all three genotypes investigated. In turkeys 
infected by aerosol, the primary site of replication is the 
upper respiratory tract, where epithelial cells become infected. 
Subsequently, epithelial cells of the lower respiratory tract 
and macrophages throughout the respiratory tract become 
infected. Then, intense replication occurs in the respiratory 
tract. At the same time, chlamydiae can be demonstrated in 
plasma and monocytes, indicating septicemia, and chlamydiae 
appear in epithelial cells and macrophages of various tissues 
throughout the body. 
In turkeys, an experimental infection with a genotype B 
strain induced much milder clinical signs and lesions than 
infection with genotype A or D strains (132). Genotype B strain 
had a longer incubation period, took longer to reach maximum 
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titers in the tissues, and had shorter periods during which the 
organism was found in the tissues. 
The incubation period of chlamydiosis in naturally infected 
birds varies, depending upon the number of chlamydiae inhaled, 
the virulence or pathogenicity of the infecting strain for that 
host species and host immunogenetics. Experimentally, definitive 
disease signs in young turkeys receiving a virulent strain may 
be evident in 5–10 days. In birds naturally exposed to smaller 
doses or in older birds, the period may be longer. Strains of 
lower virulence, which cause less severe signs, may have longer 
incubation periods. Clinical signs may not be noticeable until 
2–8 weeks after exposure. 
Signs of chlamydiosis in turkeys infected with virulent 
strains are cachexia, anorexia, elevated body temperature, 
conjunctivitis, and respiratory distress. The birds excrete 
yellow-green, gelatinous droppings. Egg production of severely 
affected hens declines rapidly to 10–20% and may temporarily 
cease or remain at a very low rate until complete recovery. 
Disease signs in a flock infected with strains of low virulence 
are usually anorexia and loose, green droppings in some birds, 
with less effect on egg production. 
At the peak of disease in a flock infected with a virulent 
strain, 50–80% of the birds will show clinical signs, and 
morbidity from less virulent strains is only 5–20%. Mortality 
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caused by virulent chlamydia ranges from 10–30% and is only 1–4% 
with less virulent strains. 
The less virulent strains cause gross lesions, which are 
similar to those caused by virulent strains, only less severe 
and extensive. In overwhelming infections with virulent strains, 
lungs show diffuse congestion, and the pleural cavity may 
contain fibrinous exudate. In fatal cases, a dark transudate may 
fill the thoracic cavity. The pericardial membrane is thickened, 
congested, and coated with fibrinous exudate. The heart may be 
enlarged, and its surface may be covered with thick fibrin 
plaques or encrusted with yellowish, flaky exudate (Fig. 24.5). 
The liver is enlarged and discolored and may be coated with 
thick fibrin. Air sacs are thickened and heavily coated with 
fibrinous exudate (Fig. 24.6). The spleen is enlarged, dark, and 
soft and may be covered with gray-white spots representing areas 
of focal cellular proliferation. The peritoneal serosa and 
mesentery show vascular congestion and may be coated with foamy, 
white fibrinous exudate. All of these exudates contain large 
numbers of mononuclear cells in which numerous micro colonies of 
chlamydial RBs may be seen. Fibrinous exudates, found on all 
organs and tissues of the thoracic and peritoneal cavities, 
reflect vascular damage as well as increasing inflammatory 
response caused by the continued multiplication of the 
organisms. In birds that survive infection with a strain of low 
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virulence, the lungs may not be seriously affected. However, 
multiplication of organisms on the epicardium may result in the 
formation of one or more fibrin plaques. 
Vanrompay et al. (130), examined histopathologic changes in 
four groups of 20 specific-pathogen-free (SPF) turkeys, kept in 
isolation units and inoculated by the natural route of infection 
(aerosol). Turkeys were experimentally infected with strain 
84/55 (C. psittaci genotype A), isolated from a parakeet, strain 
92.1293 from a turkey (C. psittaci genotype D), the Texas Turkey 
strain (C. psittaci genotype D), or strain 89/1326 (C. psittaci 
genotype B) from a pigeon. All four strains proved to be 
pathogenic for SPF turkeys. Turkeys showed conjunctivitis, 
sinusitis, rhinitis, keratitis, pericarditis (Fig. 24.5), 
pneumonia, airsacculitis (Fig. 24.6), hepatosplenomegaly, 
enteritis, congestion of the kidneys, and congestion of the 
ovaries or testes. There were epithelial erosions and fibrin 
deposit in the conjunctivae (Fig 24.7), corneal ulceration, 
bronchopneumonia (Fig. 24.8), fibrinous necrotizing 
airsacculitis (Fig. 24.9), fibrinous pericarditis, interstitial 
nephritis, peritonitis, and catarrhal enteritis. The type and 
distribution of the lesions was similar for genotypes A and D. 
The lesions produced after the genotype A infection, however, 
appeared more severe. For genotype B, in comparison with both 
other genotypes, no lesions were observed in the small 
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intestine, the pancreas, ovary, and testis. 
Controlled dual infections in SPF turkeys demonstrated the 
pathogenic interplay between C. psittaci, the avian 
metapneumovirus (aMPV: formerly named the turkey rhinotracheitis 
virus or TRT virus), and E. coli.  Escherichia coli is a 
predisposing factor for the outcome of a C. psittaci infection.  
In its turn, E. coli can increase the severity of a C. psittaci 
infection and can reactivate a latent C. psittaci infection 
(121). An aMPV infection during the acute phase of a C. psittaci 
infection aggravates the severity of clinical signs, macroscopic 
lesions, pharyngeal aMPV excretion, and histological tracheal 
lesions. However, no clear interaction was established after 
aMPV infection in latently C. psittaci-infected turkeys (122).  
Chickens 
Epidemiologic evidence formerly indicated that chickens are 
relatively resistant to disease caused by C. psittaci. Acute 
infection progressing to disease and mortality only occurred in 
young birds, and the incidence of actual epidemics was very low. 
Most natural infections in chickens were believed to be 
inapparent and transient. However, C. psittaci strains isolated 
from turkeys did cause similar pathology and mortality in 
chickens as in turkeys (111, 112).  
Recently, highly virulent C. psittaci strains have been 
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isolated from the lungs of diseased chickens raised in Belgium, 
France, Germany and China (35, 65, 146; Vanrompay et al., 2012, 
unpublished results). The strains obtained from Belgian and 
French farms were genotype D and could successfully be used to 
reproduce the disease in experimentally infected SPF chickens 
(Vanrompay et al., 2012, unpublished results). Chickens showed 
conjunctivitis, rhinitis, pneumonia, fibrinous airsacculitis, 
fibrinous pericarditis and hepatosplenomegaly. Mortality was 
observed. 
Ducks and Geese 
Chlamydiosis in domestic ducks is important both economically 
and as a public health hazard in especially, Australia, China 
and Europe (8, 9, 17, 24, 49, 50, 57, 64, 67, 69, 72, 82, 142). 
Chlamydiosis in ducks is usually a severe, debilitating, often 
fatal disease in which young ducks develop trembling, imbalanced 
gait, and cachexia. They become anorexic with green, watery 
intestinal contents. They develop a serous to purulent discharge 
from the eyes and nostrils causing the feathers on the head to 
become encrusted with exudate. As the disease progresses, the 
ducks become emaciated and die in convulsions. Morbidity ranges 
from 10–80%, and mortality varies from 0–30% depending on age 
and the presence of concurrent infections. Recently, severe 
outbreaks associated with human disease were reported in France 
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(65).  
Incidental to studies of chlamydiosis in ducks, several 
investigators have observed C. psittaci antibodies or the 
disease in geese and have isolated C. psittaci from diseased 
tissues (1). Clinical disease and necropsy findings were similar 
to those in ducks. 
Pigeons 
The incubation period for chlamydiosis in pigeons is not 
known. Infection is endemic and is believed perpetuated 
primarily by a parent-to-nestling transmission cycle (39, 101).  
Signs of uncomplicated chlamydiosis in pigeons are variable, 
but those that develop acute disease are anorexic, unthrifty, 
and diarrhetic (71). Some develop conjunctivitis, swollen 
eyelids, and rhinitis. Respiratory difficulty is accompanied by 
rattling sounds. As disease progresses, birds become weak and 
emaciated. Recovered birds become carriers without signs of 
disease. Some birds progress through an infection showing no 
signs or, at the most, transient diarrhea before becoming 
carriers. Salmonellosis or trichomoniasis exacerbates the 
illness in chlamydia-infected carrier birds, inducing signs and 
lesions of acute disease. Serologic surveys indicate that 
infection rates in pigeons of 30–90%, and active infection 
rates, as measured by isolation, of 20% are common (90, 101). 
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Gross lesions of uncomplicated chlamydiosis in pigeons are 
fibrinous exudates on thickened air sacs, the peritoneal serosa, 
and occasionally the epicardium. The liver is usually swollen, 
soft, and discolored. The spleen may be enlarged, soft, and 
dark. Greater than normal amounts of urates are seen in cloacal 
contents if catarrhal enteritis occurs. In less severe 
infections, only the liver or air sacs are involved. Some 
heavily infected shedders have no lesions (87, 90).  
Pheasants, Quail, Guinea fowl, Peacocks and Partridges 
Chlamydiosis has been reported in farm-raised pheasants, 
quail, peacocks, guinea fowl and partridges all over the world 
(32). The clinical signs and lesions are similar to those seen 
in other birds. Morbidity and mortality can be very high, 
especially in young birds. Human infections have been reported 
(31, 45, 65, 75, 110, 142).  
$b$ Immunity 
Natural immunity to chlamydia is generally poor and short-
lived. As birds become older, however, they become more 
resistant to clinical disease, even though infection may occur. 
Indeed, some birds, notably pigeons, are refractory to disease-
producing infection even with highly virulent strains. 
The immune response to Chlamydia is a coordinated event where 
innate immune cells, B cells and T cells act in concert and 
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where each of these immune effectors have roles in recognizing 
different stages of the infection. To date, chlamydial vaccine 
studies suggest that the ideal, efficacious vaccine should 
induce systemic CD4+ T helper (Th) 1 responses, but also a 
humoral response as B cells are important antigen presenting 
cells in the activation of antigen-specific memory Th2 cells 
(95).  
Less is known on innate immune detection of Chlamydia (93). 
Beeckman et al., (12) determined the cytokine responses 
following C. psittaci infection of avian monocytes/macrophages. 
High IL-10 and no TGF-β4 responses were observed at 4h post 
inoculation. This could induce macrophage deactivation and NF-κB 
suppression and thereby, could dampen innate immunity and 
promote C. psittaci survival in macrophages. 
$a$ Diagnosis 
$b$ Specimen Collection and storage of samples 
Laboratory diagnosis of avian chlamydiosis usually includes 
isolation and/or identification of the organism from the host. 
Isolation requires inoculation of cell cultures, embryonated SPF 
chicken eggs or mice with living C. psittaci. Specimens should 
be collected aseptically, as contaminant bacteria may interfere 
with isolation of the chlamydiae.  
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Proper handling of clinical samples is necessary to prevent 
loss of infectivity. If specimens are used to inoculate animals 
or cell cultures immediately, most diluents will be adequate; 
however, if the specimen is to be shipped or stored, a special 
diluent should be used. A diluent consisting of sucrose–
phosphate–glutamate (SPG) was developed for Rickettsiae and has 
proven satisfactory for transport of chlamydial field samples 
(105). The recommended medium for chlamydiae consists of SPG 
buffer (sucrose, 74.6 g/liter; KH2PO4, 0.512 g/liter; K2HPO4, 
1.237 g/liter; and L-glutamic acid, 0.721 g/liter), which can be 
sterilized by autoclaving. To this is added fetal calf serum 
(10%), vancomycin and streptomycin (100 mg/ml), and nystatin and 
gentamicin (50 mg/ml). The antibiotics reduce the effect of 
contamination even when samples are shipped at ambient 
temperatures. This medium also serves as a laboratory diluent 
and a medium for freezing of chlamydiae.  
For isolation, the following samples should be preferably 
collected: pharyngeal/choanal slit swabs in live birds (4, 129). 
Cloacal swabs or fresh faeces are less optimal as chlamydial 
shedding is intermittent. In dead birds, lungs, spleen, liver, 
thickened exudate-coated air sacs and free exudates can be 
sampled. The samples should not be frozen if they can be 
processed in 2–3 days. Otherwise they should be stored at -80°C. 
The same tissues can be collected for antigen detection, 
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PCR and other molecular tests. If the DNA extraction will not be 
done immediately, it may be beneficial to collect the specimen 
in a DNA stabilization buffer (25).  
The stability of chlamydiae during storage depends upon the 
material in which it is contained. Chlamydiae in tissue 
specimens or yolk-sac suspension can be preserved indefinitely 
by storage at -80° C (1). Note that chlamydiae harvested from 
cell culture require special media during freezing. A 
satisfactory method for freezing them is to replace the cell 
culture medium with SPG buffer before freezing, as the organism 
is highly susceptible to the presence of sodium ions in the 
medium (105).  
$b$ Microscopic examination of specimens 
$c$ Cytological and Immunohistochemical staining  
Chlamydiae can be detected in smears of exudates and faeces 
and in impression smears of tissues by cytological stainings as 
mentioned formerly. However, none of the stainings specifically 
detects chlamydia and they are all less sensitive than antibody-
based antigen detection methods or specific nucleic acid 
amplification techniques (NAATs) (7, 136). Therefore, the use of 
a cytological staining is loosing popularity. 
Nowadays, imunohistochemistry (115) is not very often used 
for routine diagnosis. It is more in use for research or 
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retrospective examination of samples for chlamydiae, if 
necessary.  
 
$b$ Antigen Enzyme-linked immunosorbent assays  
A number of manufacturers produced enzyme-linked 
immunosorbent assay (ELISA) kits for detection of Chlamydia 
trachomatis in humans. These test kits detect Cp. psittaci as 
they react to the lipopolysaccharide (LPS) or family 
(Chlamydiales) antigen. ELISA is rapid, does not require a high 
level of expertise, and is safe for the technician because the 
sample can be inactivated. A number of the test kits have been 
evaluated for use in avian samples (133), although none of the 
kits are licensed for C. psittaci. These kits detect the 
lipopolysaccharide antigen which gave false positives as the 
chlamydial LPS shares epitopes with the LPS of other gram-
negative bacteria. The more recently developed ELISA’s use more 
specific monoclonal antibodies. However, these kits still lack 
sensitivity: a few hundred organisms are needed for a positive 
reaction. The general rule with these tests is that a diagnosis 
of chlamydiosis can be made when a strong positive reaction is 
seen along with clinical signs of chlamydiosis.  
 
$b$ Isolation  
$c$ Preparation of inoculum  
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Tissue specimens, fecal samples, and swabs are routinely 
used as samples for the isolation of Chlamydia. Before the 
inoculation samples must be treated properly. The processing of 
the samples is similar for inoculation of cell cultures or 
embryonated eggs. A number of laboratories are using SPG buffer, 
or transport medium (105) as diluent. These diluents have the 
advantage of stabilizing the agent during refrigeration or 
freezing of the samples. Penicillin and tetracyclines should be 
avoided, as they will inhibit the growth of C. psittaci.  
A standard procedure is to prepare 20% tissue suspensions 
in diluent. The suspensions are centrifuged (2790 x g, 4°C) for 
10 min. The supernatants are collected and 10 µl/ml streptomycin 
sulphate (streptomycin sulphate 1% w/v) and 20 µl/ml vancomycin 
(vancomycin 0.5 w/v) are added. If needed 0.1% amphotericin B 
can be added. After one hour of incubation at room temperature 
the suspensions are centrifugated for 30 min (2790 x g, 4°C) and 
supernatants are immediately used for inoculation or stored at -
80°C until use. Swabs are shaken for 1 hour at 4°C a rocking 
platform, centrifuged (2790 x g, 4°C) and the supernatant 
immediately used or stored at -80°C until use. Faecal samples, 
although not preferably used for diagnosis because of the 
intermittent chlamydia shedding and the risk for false 
negatives, are processed as follows. A 20% suspension is made in 
diluent and the suspension is shaken for 1 hour (4°C) on a 
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rocking platform. Afterwards, the suspension is sonicated for 10 
min using an ultrasonic water bath. The supernatant is collected 
and 10 µl/ml streptomycin sulphate (streptomycin sulphate 1% 
w/v), 20 µl/ml vancomycin (vancomycin 0.5 w/v) and 0.1% 
amphotericin B are added. The suspension is incubated at room 
temperature (1 hour) and subsequently centrifuged (2790 x g, 
4°C) for 30 min. The supernatant is collected and thereafter 
ultracentrifugated (45,000 x g, 4°C, 45 min). The supernatant is 
discarded and the remaining chlamydia pellet is resuspended in 
dileunt and immediately used for inoculation or stored at -80°C 
until use. 
 
$c$ Cell cultures and SPF embryonated chicken eggs  
Cell cultures are the most common and convenient method for 
the isolation of C. psittaci. The most commonly used cell lines 
are BGM, Vero, McCoy, HeLa, and L-929, although a number of 
other cell cultures, like chickens embryo fibroblasts can be 
used. A study showed BGM to be the most sensitive, with Vero and 
L-929 listed as satisfactory (136). Standard cell culture medium 
is used, containing 5%–10% fetal calf serum and antibiotics like 
vancomycin, streptomycin and amphotericin B as they do not 
inhibit the growth of C. psittaci.  
The culture equipment must be suitable for the following 
procedures: i) identification by fluorescent antibody (FA) or 
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another appropriate technique of staining of the infected 
monolayer, ii) centrifugation (500-1500 x g for 60 to 90 min)of 
the inoculum onto the monolayer at 37°C to enhance infectivity 
(eventually in the presence of DEAE), iii) possible blind 
passages at 3 or 6 days post inoculation to increase sensitivity 
of isolation, iv) examination of the sample 2 to 3 times during 
passage, v) protection of humans against possible infection. 
Small flat-bottomed vials (1-dram shell vials) or bottles, with 
12-mm diameter glass coverslips, will meet these requirements 
and are often used because the cell culture monolayer can be 
grown directly on the coverslip. Several vials are inoculated 
with each sample to permit fixing and staining at various times 
and to permit passages of negative samples after 6 days of 
incubation.  
Chlamydiae can be isolated from cells that are replicating 
normally. Most diagnosticians, however, prefer to use non-
replicating host cells for two reasons: i) to provide increased 
nutrients for the replication of chlamydiae, and ii) because 
non-replicating cells can be maintained for longer periods for 
observation. Host-cell replication is suppressed most commonly 
using cycloheximide (0.5-2.0 mg/ml). Incubation is usually at 
37–39 °C, depending on the cell culture used. Disruption of the 
monolayer by freeze-thawing should be avoided, as it can destroy 
C. psittaci.  
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Some laboratories still use chicken embryos for primary 
isolation of chlamydiae. The standard procedure is to inject up 
to 0.3 ml of inoculum into the yolk sacs of 6-day-old embryos 
(136). Replication of chlamydia usually will cause the death of 
the embryo within 5–12 days after inoculation. If no deaths 
occur, two additional blind passages are usually made before 
calling the sample negative. Chlamydia infection typically 
causes vascular congestion of the yolk-sac membranes, which are 
harvested and homogenized as a 20% yolk-sac suspension. This 
suspension can be frozen (-80°C) to preserve the strain or 
inoculated into other eggs if needed or into cell culture 
monolayers. C. psittaci is usually identified by 
immunofluorescence staining of yolk-sac impression smears. 
 
$c$ Staining cell monolayers or yolk-sac impression smears  
The preferred method for fixing of the monolayer is to 
remove the medium, wash once with PBS, and fix with cold acetone 
for 10 min (-20°C). If the cell culture vessel is plastic, the 
monolayer can be fixed with a mixture of 50% acetone and 50% 
methyl alcohol or with 100% methyl alcohol. The preferred method 
for staining is the fluorescence method. With the fluorescence 
method, the fluorescein-conjugated anti-chlamydia serum is 
applied to the glass slide and incubated for minimum 30 min at 
37° C. The slides are then washed with PBS and aqua dest, air-
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dried, and mounted to be monitored by use of a fluorescence 
microscope. Commercially fluorescently labeled monoclonal 
antibodies are available. Conjugates also can be prepared from 
polyclonal sera from rabbits, guinea pigs, sheep, or goats. The 
fluorescein-labeled conjugate is than prepared using standard 
conjugation techniques. 
 
$b$ nucleic acid amplification techniques 
The possibilities of diagnostic detection of Chlamydia 
psittaci are considerably improved with the introduction of 
molecular methods, which permit direct identification from 
clinical specimens and accelerates diagnosis from several days 
to a single working day. Tests published in the literature 
mainly utilize two different genomic target regions for 
amplification, namely the ribosomal RNA gene region (34, 53, 55, 
56, 74).  
The sensitivity of the PCR largely depends on the amount and 
quality of the extracted DNA. Optimal extraction of nucleic 
acids from a wide range of clinical samples is one of the most 
under appreciated, but nevertheless challenging and important 
steps. Proper extraction must efficiently release nucleic acids 
from samples, remove PCR inhibitors, avert the degradation of 
nucleic acids, and ensure adequate concentration of the nucleic 
acids after extraction. This is relatively easy achievable for 
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viral and mammalian amplification targets, but much more 
difficult for nucleic acid targets of bacteria. Several in-
house-made and commercial DNA extraction methods have been 
described (25, 100). The use of commercial kits can be 
recommended especially when dealing with PCR inhibitors. They 
contain a special buffer reagent for lyses of the bacterial and 
eukaryotic host cells mostly based on a guanidine- detergent 
lysing solution. Simultaneous disruption of cells and 
inactivation of nucleases is achieved by lysis in strong 
denaturing reagents, for instance 4M guanidinium isothiocyanate 
or 4M guanidinium-hydrochloride.  
Tissue sample homogenization in cell culture medium, PBS, or 
Tris buffered saline and/or freeze-thaw cycles of samples lead 
to rapid loss of chlamydial target DNA. Specimens that contain 
low target numbers before freezing often become negative after 
cryostorage. The preservation of DNA from degradation is 
critically important. DeGraves et al., (25) advise to collect 
all specimens for PCR analysis in a DNA stabilization reagent. 
Such reagents are commercially available; for instance the 
RNA/DNA Stabilization Reagent for Blood/Bone Marrow® from Roche 
Applied Science.  
Nested PCR procedures are more sensitive than traditional PCR 
and in most cases are also more sensitive than real-time PCR. 
However, they are more time-consuming. False positives can more 
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easily occur due to post-PCR carry over. Two highly sensitive 
nested PCR assays have been developed to detect C. psittaci 
(100, 124). Recently, a SYBR Green-based real-time PCR was 
developed targeting the rDNA ribosomal spacer of C. psittaci 
(37).  
Sachse et al., (99) developed a DNA microarray-based 
detection and identification method for Chlamydia spp. The test 
uses the ArrayTube platform technology (CLONDIAG®chip 
technologies). The company has also developed an ompA-based C. 
psittaci genotyping microarray (31). 
 
$b$ Serology 
Serology alone is not particularly useful in diagnosing a 
current chlamydial infection in birds because of the high 
prevalence of this infection in birds and the long-term, up to 
several months, persistence of anti-chlamydial antibodies. In 
most bird species, there is a high background rate of anti-
chlamydial antibodies, and until we have more information on the 
disease pattern in certain bird species in relation to direct 
identification of the bacteria and serology, we are unable to 
comment on the real significance of antibody titers obtained. 
Thus, to determine if a single bird is infected, serology should 
always be used in conjunction with antigen or gene detection or 
paired sera should be examined. However, obligatory examination 
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of paired sera removes serology from immediate clinical 
relevance. A positive test is evidence that the bird was 
infected by the bacterium but does not necessarily indicate an 
active infection. False negative results can occur in birds with 
acute infections that are sampled before sero-conversion. 
Treatment with antibiotics may also delay and/or diminish the 
antibody response. The main serological methods that are being 
used for detecting chlamydial antibodies are: 1) various methods 
of elementary body agglutination (EBA) (47), 2) the complement 
fixation test (CF) (47), 3) an indirect (micro) 
immunofluorescence (MIF) test and 4) several commercial ELISAs.  
The EBA detects primarily IgM antibodies and thus can detect 
early infections (43-45). A negative result does not guarantee 
that a bird is free of infection as the sensitivity of the test 
is rather low. The direct complement fixation (DCF) test detects 
avian IgG but not IgM. Disadvantages are: 1) test antigens 
commercially unavailable, 2) the test can not be used for 
testing sera from avian species whose immunoglobulins do not fix 
complement, 3) it is only relatively sensitive, 4) it cannot be 
used to differentiate between IgG and IgM antibodies, and 5) 
fairly laborious when there is a large number of samples to be 
tested. The modified DCF test is more sensitive but has the same 
disadvantages as the DCF test (45, 46). The indirect IF test 
detects all immunoglobulin isotypes and is, as is the MIF test, 
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widely used to detect C. trachomatis, C. pneumoniae and C. 
psittaci antibodies in human sera. The MIF test appears to be 
more sensitive than the complement fixation tests. Some years 
ago a large number of commercially available ELISAs were 
evaluated for demonstrating C. psittaci antibodies in birds. All 
of these ELISAs were highly sensitive but showed low 
specificity, as they were mainly based on the use of whole 
chlamydial organisms, LPS, or chlamydial outer membrane 
fractions of LPS and lipoglycoprotein nature (1). More recently, 
peptide-based ELISA systems, or ELISAs using recombinant LPS, 
have become commercially available for the specific detection of 
C. trachomatis, C.pneumoniae and C.abortus antibodies (Medac, 
Savyon, Labsystems), (1). These tests performed as well as the 
MIF assay, but are less time-consuming, less expensive, and 
easier to perform. In the future this principle might also be 
useful in the serodiagnosis of C. psittaci infections. At 
present, an ELISA using recombinant MOMP of C. psittaci has 
already been described (139) for testing avian sera. The test 
detects antibodies against all Chlamydia species. 
$b$ Differential Diagnosis 
Suspected chlamydiosis may have to be differentiated from 
pasteurellosis, particularly in turkeys, in which some signs and 
lesions may be similar. Pasteurellosis can be ruled out by 
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appropriate culture procedures. Because of some similar signs 
and lesions, Ornithobacterium rhinotracheale infections and 
mycoplasmosis may need to be ruled out in turkeys and chickens 
suspected of having chlamydiosis. That can be accomplished by 
culturing and serologic testing. Colibacillosis may mimic 
chlamydiosis to some extent; it can be excluded by the use of 
the appropriate coliform culturing procedures. Avian influenza 
or aMPV may have to be ruled out in suspected chlamydiosis by 
virus isolation attempts and by serologic testing. 
$a$ Intervention Strategies 
$b$ Management Procedures 
Ideally birds should be reared in confinement without any 
contact with potentially contaminated equipment or premises. 
Contact with potential reservoirs or vectors such as pet birds, 
rodents, arthropods, and wild and feral birds should also be 
prevented. General sanitation must be practiced diligently. 
Movement of people should be restricted so that visitors do not 
have free access to premises holding birds. This is easier to 
accomplish if birds are confined in houses and if the ‘all-in-
all-out’ principle is used on the farm. 
Recently, C. psittaci bioaerosol monitoring came available 
and this could be used for monitoring the infection pressure in 
the poultry industry (117, 119). 
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$b$ Vaccination  
Commercial chlamydia vaccines for poultry are not available. 
Protective immunity to Chlamydiaceae is believed to be 
effected primarily through the action of CD4+ T helper type 1 
(Th1) lymphocytes, CD8+ T lymphocytes, mononuclear phagocytes, 
and cytokines secreted by these cells. In addition, the role of 
local antibodies in mucosal secretions is not to be 
underestimated. The only protective chlamydial antigen that has 
been unambiguously identified is the major outer membrane 
protein (MOMP). However, attempts at chlamydial vaccine 
development based on a subunit design using MOMP have generally 
failed, probably because the immunogens did not induce the 
protective cellular and humoral immune responses elicited by 
native bacterial epitopes. In light of the current knowledge on 
protective chlamydial immunity, plasmid DNA expressing the MOMP 
of C. psittaci has been tested for its ability to raise a 
protective immune response in SPF turkeys against challenge with 
C. psittaci strains (126, 137). Effective priming of T cell 
memory and significant reduction in clinical signs, lesions, 
bacterial excretion and C. psittaci replication in tissues was 
observed.   
$b$ Prevention by means of ovotransferrin 
Recently, ovotransferrin (natural anti-microbial protein) was 
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successfully used to reduce clinical signs, lesions, excretion, 
and chlamydia replication in experimentally infected SPF turkeys 
(120). Next, C. psittaci infection pressure on a turkey broiler 
farm was significantly reduced by administering ovotransferrin 
aorosols. Ovotransferrin significantly reduced respiratory 
disease, mortality and antibiotic use on the farm (117).  
$b$ Treatment 
Chlamydiosis treatment for poultry is not changed over the 
years (1, 104, 131). The drug of choice varies from country to 
country. Tetracylines are the drugs of choise; chlortetracycline 
and doxycycline are most often used. Enrofloxacine 
(fluoroquinolone antibiotic) can be used. Turkeys can be treated 
with chlortetracycline (CTC) at a concentration of 400 g/ton of 
pelleted feed. Care must be taken so that heat produced during 
the pelleting process does not destroy CTC and lower the 
concentration below an effective level. The CTC-medicated feed 
must be given for 2 weeks and then replaced by non-medicated 
feed for 2 days prior to the birds being slaughtered for meat 
for human consumption. Calcium supplement should not be added to 
CTC-medicated pellets because calcium ions chelate CTC and 
diminish its effectiveness. Turkeys can also be treated with 
doxycycline hyclate formulations for drinking water (doxycycline 
hyclate 500mg/g; dose of 20 mg/kg BW per day) for 5 days or 
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enrofloxacin (100 mg/ml) at a daily dose of 10 mg of 
enrofloxacin per kg of body weight, in water for 3 to 5 days and 
in case of mixed or chronic infections for 5 to 10 days. 
Medicated drinking water should be replaced every 24 hours. It 
is recommended that all turkeys on an infected premise be 
treated.  
Essentially the same treatment methods are used to treat 
other fowl infected with C. psittaci. In other birds, 
salmonellosis may often be a complicating factor so it may be 
necessary to use a combination of antibiotics. Treatment may not 
be effective in eliminating the carrier state. Additional 
periods of treatment may be needed, especially when birds are 
kept for several weeks.  
$b$ State Regulations 
Because regulations may vary from state to state, the 
appropriate public health and/or animal health agencies should 
be consulted as necessary. In many countries, psittacosis 
(humans) and even chlamydiosis in poultry are notifiable 
diseases and must be reported within 48 h. 
According to USDA regulations, movement of poultry, 
carcasses, or offal from any premise is prohibited where the 
existence of chlamydiosis has been proved by isolation of a 
chlamydial agent. The Animal and Plant Health Inspection Service 
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of the USDA and the U.S. Department of Health and Human Services 
forbid interstate movement of birds from infected flocks, but 
there is no restriction on movement of eggs from such flocks.  
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Figures 
 
24.1.  Buffalo green monkey (BGM) cell culture, 1 hour after 
inoculation with the C. psittaci Texas Turkey genotype D strain 
showing an elementary body (EB) attached to the side of a host 
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cell microvillus. 
 
24.2. Buffalo green monkey (BGM) cell culture, 18 hours after 
inoculation with a C. psittaci genotype B strain (89/1326). Note 
the vacuole near the nucleus (N) with an early and late stage of 
division of a reticulate body (R). Note the “hour-glass” profile 
(arrow H).  
 
24.3.  BGM cell culture, 52 hours after inoculation with a C. 
psittaci genotype D strain (92/1293), isolated from diseased 
turkeys. Note the large inclusion and the elementary bodies (EB) 
apparently “escaping” from the inclusion. Also notice the 
mitochondria (M) lining the inclusion. 
 
24.4. BGM microcarrier culture, 50 hours post inoculation with 
the C. psittaci Texas Turkey genotype D strain showing lysis of 
an infected BGM cell. The cell is sloughing of the microcarrier 
(MC). Note the presence of elementary bodies (E), reticulate 
bodies (R) and intermediate bodies (I).  
 
24.5. Turkey experimentally infected (aerosol) with a C. 
psittaci genotype A strain (84/55) isolated from the lungs of a 
budgerigar. Note the presence of serous fluid together with 
fibrin in the pericardial sac.  
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24.6. Turkey experimentally infected (aerosol) with a C. 
psittaci genotype A strain (84/55). Note the thickened abdominal 
airsac totally covered with fibrin cloths (arrow).  
 
24.7. Hematoxylin and eosin staining of experimentally infected 
turkeys. Conjunctiva with infiltration of lymphocytes and 
heterophils together with epithelial vacuolization and 
hyperplasia (x172).  
 
24.8. Hematoxylin and eosin staining of experimentally infected 
turkeys. Congested lung with infiltration of lymphocytes (arrow 
A) and dilated bronchi and parabronchi (arrow B) (x69).  
 
24.9. Hematoxylin and eosin staining of experimentally infected 
turkeys. Fibrinous necrotizing airsacculitis (x172).  
